Crossmark

Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts

Crossref DOI link: https://doi.org/10.1007/s10238-016-0409-2

Published Online: 2016-03-19

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tai, Cheng-Jeng

Wang, Hang

Wang, Chien-Kai

Tai, Chen-Jei

Huang, Ming-Te

Wu, Chih-Hsiung

Chen, Ray-Jade

Kuo, Li-Jen

Wei, Po-Lei

Chang, Yu-Jia

Chang, Chun-Chao

Chiou, Hung-Yi

Wu, Chang-Jer
License Information

Text and Data Mining valid from 2016-03-19